ࡱ> a pjbjb 0jBjjjjtވB2>؉ ,LRlvvvv~:vvvUh jv0 v vBB$CfFBBBfFAtkins CE, Brown WA, Coats JR, Crawford MA, DeFrancesco TC, Edwards J, Fox PR, Keene BW, Lehmkuhl L, Luethy M, Meurs K, Petrie JP, Pipers F, Rosenthal S, Sidley JA, Straus J (2002) Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation J Am Vet Med Assoc. 2002; 22: 654-8 Atkins CE, Keene BW, Brown WA, Coats JR, Crawford MA, Defrancesco TC, Edwards NJ, Fox PR, Lehmkuhl LB, Luethy MW, Meurs KM, Petrie JP, Pipers FS, Rosenthal SL, Sidley JA, Straus JH (2007) Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency J Am Vet Med Assoc. 2007; 231: 1061-9 Atkins CE, Rausch WP, Gardner SY, Defrancesco TC, Keene BW, Levine JF (2007) The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog J Vet Pharmacol Ther. 2007; 30: 394-400 Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S, Hggstrm J, Hamlin R, Keene B, Luis-Fuentes V, Stepien R (2009) Guidelines for the diagnosis and treatment of canine chronic valvular heart disease J Vet Intern Med. 2009; 23:1142-50 Atkins CE (2007) ACE-inhibitors in asymptomatic mitral regurgitation In: Proceedings of the NAVC Congress. Orlando, 2007, 144 Atkinson KJ, Fine DM, Thombs LA, Gorelick JJ, Durham HE (2009) Evaluation of pimobendan and N-terminal probrain natriuretic peptide in the treatment of pulmonary hypertension secondary to degenerative mitral valve disease in dogs J Vet Intern Med. 2009; 23: 1190-6 Bach JF, Rozanski EA, Macgregor J, Betkowski JM, Rush JE (2006) Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs J Vet Intern Med. 2006; 20: 1132-5 Bernay F, Bland JM, Hggstrm J, Baduel L, Combes B, Lopez A, Kaltsatos V (2010) Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease J Vet Intern Med. 2010; 24: 331-41 Bomassi E (2007) Principe actif le pimobendane Nouv. prat. vt. canine fline. 2007; 31: 60-63 Bomassi E (2006) Thrapeutique. Lutilisation raisonne des IECA lors dinsuffisance cardiaque chez le chien et le chat Nouv. Prat. Vt. canine fline. 2006, 33-3 Bonagura JD, Schober KE (2009) Can ventricular function be assessed by echocardiography in chronic canine mitral valve disease? J Small Anim Pract. 2009;50 Suppl 1:12-24 Booth MA, Atkins CE, Fujii Y, Adams AK, Defrancesco TC, Keene BW (2007) The effect of pimobendan on the renin-angiotensin-aldosterone system and arrhythmogenesis in the dog J Vet Intern Med. 2007; 21: 610-1 Borgarelli M, Tarducci A, Zanatta R, Haggstrm J (2007) Decreased systolic function and inadequate hypertrophy in large and small breed dogs with chronic mitral valve insufficiency J Vet Intern Med. 2007; 21: 61-67 Borgarelli M, Savarino P, Crosara S, Santilli RA, Chiavegato D, Poggi M, Bellino C, La Rosa G, Zanatta R, Haggstrom J, Tarducci A (2008) Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease J Vet Intern Med. 2008; 22: 120-8 Boswood A (2008) Comment je traite La Maladie Valvulaire Dgnrative chez le chien Veterinary Focus. 2008; 18: 25-31 Boswood A (2009) New standard of care in canine CHF treatment: what do the clinical trials mean for the veterinary practitioner? In: Proceedings of the NAVC Conference. Orlando, 2009, 179-181 Buchanan JW (1977) Chronic valvular disease (endocardiosis) in dogs Advt Vet Sci. 1977; 21: 57-10 BULMER BJ, SISSON DD (2005) Therapy of heart failure In: Ettinger SJ, Feldman EC, editors, Textbook of veterinary internal medicine, diseases of the dog and cat. St-Louis: Elsevier Saunders; 2005, 948-72 Capomolla S, Pozzoli M, Opasich C, Febo O, Riccardi G, Salvucci F, Maestri R, Sisti M, Cobelli F, Tavazzi L (1997) Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function Am Heart J. 1997; 134: 1089-98 Chandrashekhar Y, Prahash AJ, Sen S, Gupta S, Roy S, Anand IS (2003) The role of arginine vasopressin and its receptors in the normal and failing rat heart J Mol Cell Cardiol. 2003; 35: 495-504 CHETBOUL V, POUCHELON JL, BUREAU-AMAGLIO S, TESSIER D ( 1999) Echocardiographie et examen Doppler lors de cardiopathies In: Echocardiographie et cho-doppler du chien et du chat. 1999, Masson; 69-136 Chetboul V (2002) Traitement de linsuffisance cardiaque. Choix et suivi du traitement de linsuffisance cardiaque Point. Vt. 2002; 33, numro spcial: cardiologie du chien et du chat: 22-27 Chetboul V (2006) Traitement de linsuffisance mitrale chez le chien Prat. Vt. Anim. Cie. 2006; 31: 7-10 Chetboul V, Lefebvre HP, Carlos Sampedrano C, Gouni V, Saponaro V, Serres F, Concordet D, Nicolle AP, Pouchelon JL (2007) Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded and randomized study J Vet Intern Med. 2007; 21: 742-753 Chiong JR, Cheung RJ (2010) Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue. Clin Cardiol. 2010; 33: 345-52 Chua TP, Ponikowski P, Webb-Peploe K, Harrington D, Anker SD, Piepoli M, Coats AJ (1997) Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex Eur Heart J. 1997; 18: 480-486 Corcoran BM, Black A, Anderson H, Dukes McEvan J, French A (2002) Investigation of mitral valve morphology in dogs with mitral valve endocardiosis using scanning electron microscopy In : Proceedings of the 12th European College of Veterinary Internal Medecine/European Society of Veterinary Internal Medecine Congress. Munich, 2002: 178; 19-21 Corcoran BM, Black A, Anderson H, McEwan JD, French A, Smith P, Devine C (2004) Identification of surface morphologic changes in the mitral valve leaflets and chordae tendineae of dogs with myxomatous degeneration Am J Vet Res. 2004; 65: 198-206 Crosara S, Borgarelli M, La Rosa G, Savarino P, Bellino C, Zanatta R, Haggstrom J, Tarducci A (2007) Natural history and risk predictors of chronic degenerative mitral valve disease in asymptomatic dogs J Vet Intern Med 2007; 21: 1420-1445 DARKE PGG (1987) Valvular incompetence in Cavalier King Charles spaniels Vet Rec. 1987; 120: 365-366 DAVIDOFF F, HAYNES RB, SACKETT DL, SMITH R (1995) Evidence-based medicine Br Med J. 1995; 310: 1085-6 Drexler H, Hornig B (1996) Importance of endothelial function in chronic heart failure J Cardiovasc Pharmacol. 1996; 27: S9-S12 DE MORAIS HA, SCHWARTZ DS (2005) How does the body react to heart failure? In: Ettinger SJ, Feldman EC, editors, Textbook of veterinary internal medicine, diseases of the dog and cat. St-Louis: Elsevier Saunders; 2005, 921-930 Disatian S, Ehrhart EJ 3rd, Zimmerman S, Orton EC (2008) Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation Heart Valve Dis. 2008; 17: 402-1 Drexler H, Hornig B (1996) Importance of endothelial function in chronic heart failure J Cardiovasc Pharmacol. 1996; 27: S9-12 Ettinger SJ, Benitz AM, Ericsson GF, Cifelli S, Jernigan AD, Longhofer SL, Trimboli W, hanson PD (1998) Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group J Am Vet Med Assoc. 1998; 213: 1573-7 Falk T, Jnsson L (2000) Ischaemic heart disease in the dog: a review of 65 cases J Small Anim Pract. 2000; 41: 97-103 Falk T, Jnsson L, Olsen LH, Pedersen HD (2006) Arteriosclerotic changes in the myocardium, lung, and kidney in dogs with chronic congestive heart failure and myxomatous mitral valve disease Cardiovasc Pathol. 2006; 15: 185-93 Falk T, Jnsson L, Olsen LH, TARNOW I, PEDERSEN HD (2007) Correlation of cardiac pathology and clinical findings in dogs with naturally occuring congestive heart failure In: Proceedings of the 17th annual ECVIM congress. Budapest, Hungary, 2007; Abstract 23 Freeman LM, Rusch JE (2008) Maladies cardiovasculaires: influence de lalimentation In: Encyclopdie de la nutrition clinique, Royal Canin. 2008; 335-347 Fujii Y, Orito K, Muto M, Wakao Y (2007) Modulation of the tissue renin-angiotensin-aldosterone system in dogs with chronic mild regurgitation through the mitral valve Am J Vet Res. 2007; 68: 1045-50 Gerling IC, Sun Y, Ahokas RA, Wodi LA, Bhattacharya SK, Warrington KJ, Postlethwaite AE, Weber KT (2003) Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype Am J Physiol Heart Circ Physiol. 2003;285: H813-21 GOGNY M, SOUILHEM W (2003) Principe actif la spironolactone Nouv Prat Vt canine fline. 2003; 11: 53-54 Gordon SG, Miller MW, Saunders AB (2006) Pimobendan in heart failure therapy a silver bullet? J Am Anim Hosp Assoc. 2006;42: 90-3 Hggstrm J, HANNSON K, KVART C, SWENSON L (1992) Chronic valvular disease in the Cavalier King Charles spaniel in Sweden Vet Res. 1992; 131: 549-553 Hggstrm J, hamlin rl, hansson k, kvart c (1996) Heart rate variability in relation to severity of mitral regurgitation in Cavalier King Charles spaniels J Small Anim Pract. 1996; 37: 69-75 Hggstrm J, Hansson K, Karlberg BE, Kvart C, Madej A, Olsson K (1996) Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation Am J Vet Res. 1996; 57: 1645-52 Hggstrm J, Hansson K, Kvart C, Karlberg BE, Vuolteenaho O, Olsson k (1997) Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs Am J Vet Res. 1997; 58: 77-82 Hggstrm J, Duelund Pedersen H, Kvart C (2004) New insights into degenerative mitral valve disease in dogs Vet Clin North Am Small Anim Pract. 2004; 34: 1209-26 Hggstrm J., Kvart C., Pedersen HD (2005) Acquired Valvular Heart Disease In: Ettinger SJ, Feldman EC, editors, Textbook of veterinary internal medicine, diseases of the dog and cat. St-Louis: Elsevier Saunders; 2005, 1022-35 Hggstrm J., Kvart C., Pedersen HD (2005) Heart failure In: Ettinger SJ, Feldman EC, editors, Textbook of veterinary internal medicine, diseases of the dog and cat. St-Louis: Elsevier Saunders; 2005, 405-406 Hggstrm J, Boswood A, OGrady M et al (2008) Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occuring myxomatous mitral valve disease: the QUEST study J Vet Intern Med. 2008; 22:1124-35 Hggstrm J, Hglund K, Borgarelli M (2009) An update on treatment and pronostic indicators in canine myxomatous mitral valve disease J of Small Anim Pract. 2009; 50: S25-33 Hamlin RL, Nakayama T (1998) Comparison of some pharmacokinetic parameters of 5 angiotensin-converting enzyme inhibitors in normal beagles J Vet Intern Med. 1998; 12: 93-5 Han RI, Black A, Culshaw GJ, French AT, Else RW, Corcoran BM (2008) Distribution of myofibroblasts, smooth muscle-like cells, macrophages, and mast cells in mitral valve leaflets of dogs with myxomatous mitral valve disease Am J Vet Res. 2008; 69: 763-9 Hansson K, Hggstrm J, Kvart C, Lord P (2009) Reader performance in radiographic diagnosis of signs of mitral regurgitation in cavalier King Charles spaniels J of Small Anim Pract. 2009; 50: S44-53 Harris P (1987) Congestive cardiac failure: central role of the arterial blood pressure Br Heart J. 1987; 58:190-203 Hugonnard M, Bublot I, Cador JL, Goy-thollot I (2002) Conduite thrapeutique chez le chien g qui tousse Point Vt. 2002; 33: 44-8 Kanno K, Kuse H, Kawasaki M, Hara A, Kano R, Sasaki Y (2007) Effects of pimobendan for mitral valve regurgitation in dogs J Vet Med Sci. 2007; 69: 373-7 Keene BW, Bonagura JD (2009) Management of heart failure in dogs In: Bonagure JD, Twedt DC, editors, Kirks current veterinary therapy, small animal practice. St-Louis: Elsevier Saunders; 2009, 769-86 Keene BW, haggstrom J, Boswood A (2009) Best care practices for canine heart failure treatment In: Proceedings of the NAVC Conference. Orlando, 2009, 201-2 Kellum HB, Stepien RL (2007) Sildenafil citrate therapy in 22 dogs with pulmonary hypertension J Vet Intern Med. 2007; 21: 1258-64 KEROACK S, TRONCY E (2002) Traitement durgence de ldme pulmonaire aigu Point Vt. 2002; 33, numro spcial: actualits thrapeutiques en cardiologie du chien et du chat: 112-5 Kim S, Iwao H (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases Pharmacol Rev. 2000; 52: 11-34 KITTLESON MG, JOHNSON LE, OLIVER NB (1985) Acute hemodynamics effects of hydralazine in dogs with chronic mitral regurgitation J Am Vet Med Assoc. 1985; 187: 258-61 Kittleson MD (1998) Myxomatous atrioventricular degeneration In: Kittleson MD, Kienle RD, editors, Mosby, Small animal cardiovascular medecine; 297-318 Kjaer A, Hesse B (2001) Heart failure and neuroendocrine activation: diagnostic, pronostic and therapeutic perspectives Clin Physiol. 2001; 21: 661-72 KOGURE K (1980) Pathology of chronic mitral valvular disease in the dog Jpn J Vet Sci. 1980; 42: 323-335 Kvart C, Haggstrom J, Pedersen HD, Hansson K, eriksson A, Jarvinen AK, Tidholm A, Bsenko K, Ahlgren E, Ilves M, Ablad B, Falk T, Bjerkas E, Gundler S, lord P, Wegeland G, Adolfsson E, Corfitzen J (2002) Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation J Vet intern med. 2002;16: 80-8 KVEIBORG B, MAJOR-PETERSEN A, CHRISTIANSEN B, TORP-PEDERSEN C (2007) Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial Vasc Health Risk Manag. 2007; 3: 31-7 LEFEBVRE HB (2004) Les diffrentes classes thrapeutiques In: Chetboul V, Lefebvre HP, Tessier-Vetzel D, Pouchelon JL, editors. Thrapeutique cardiovasculaire du chien et du chat. Paris: Masson-AFVAC; 2004, 17-40 Lefvre C, Goby L (2005) Le tout premier symposium sur lendocardiose mitrale chez le chien ouvre de nouveaux horizons dans le domaine de la recherche, des soins et du traitement Prat Vt Anim Cie. 2005; 24: S11-5 Lombard CW, spencer cp (1985) Correlation of radiographic, echocardiographic and electrocardiographic signs of left heart enlargement in dogs with mitral regurgitation Vet Radiol. 1985; 26: 89-97 Lombard CW, Jns O, Bussadori CM (2006) Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs J Am Anim Hosp Assoc. 2006; 42: 249-61 Mallery KF, Freeman LM, Harpster NK, Rush JE (1999) Factors contributing to the decision for euthanasia of dogs with congestive heart failure J Am Vet Med Assoc. 1999; 214: 1201-4 Marcondes Santos M, Strunz CM, Larsson MH (2006) Correlation between activation of the sympathetic nervous system estimated by plasma concentrations of norepinephrine and Doppler echocardiographic variables in dogs with acquired heart disease Am J Vet Res. 2006; 67: 1163-8 Marcondes Santos M, Tarasoutchi F, Mansur AP, Strunz CMC (2007) Effects of carvedilol treatment in dogs with chronic mitral valvular disease J Vet Intern Med. 2007; 21: 996-1001 Mullens W, Abrahams Z, Francis GS, Skouri HN, Starling RC, Young JB, Taylor DO, Tang WH (2008) Sodium nitroprusside for advanced low-output heart failure J Am Coll Cardiol. 2008; 52: 200-7 Nicolle AP, Chetboul V, Allerheiligen T, Pouchelon JL, Gouni V, Tessier-Vetzel D, Sampedrano CC, Lefebvre HP (2007) Azotemia and glomerular filtration rate in dogs with chronic valvular disease J Vet Intern Med. 2007; 21: 943-9 O'Connor CM, Carson PE, Miller AB, Pressler ML, Belkin RN, Neuberg GW, Frid DJ, Cropp AB, Anderson S, Wertheimer JH, DeMets DL (1998) Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation Am J Cardiol. 1998; 82: 881-7 Olsen L, Fredholm M, Pedersen H (1999) Epidemiology and inheritance of mitral valve prolapse in Dachshunds J Vet Intern Med. 1999; 13: 448-56 Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA (2006) Controversies in ventricular remodelling Lancet. 2006; 367: 356-67 OSullivan ML, OGrady MR, Walker C (2007) Frequency of ventricular ectopy in dogs with chronic mitral valve disease and congestive heart failure treated with pimobendan or benazepril J Vet Intern Med. 2007; 21: 587 Ouellet M, Difruscia R, belanger MC (2007) Evaluation of pimobendan in the treatement of early mitral valve disease J Vet Intern Med. 2007; 21: 610 Oyama MA, Chittur SV (2006) Genomic expression patterns of mitral valve tissues from dogs with degenerative mitral valve disease Am J Vet Res. 2006; 67:1307-18 Oyama M, Rush JE, OSullivan ML, Williams RM, Rozanski EA, Petrie JP, Sleeper MM, Brown DC (2008) Perceptions and priorities of owners of dogs with heart disease regarding quality versus quantity of life for their pets J Am Vet Med Assoc. 2008; 233: 104-8 Oyama MA (2009) Treating canine heart failure: from start to finish In: Proceedings of the NAVC Conference. Orlando, 2009, 210-1 Oyama MA (2009) How et when to use pimobendan In: Proceedings of the NAVC Conference. Orlando, 2009, 212-3 Oyama MA (2009) Neurohormonal activation in canine degenerative mitral valve disease: implications on pathophysiology and treatment J of Small Anim Pract. 2009; 50: S3-11 Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH, Cropp AB, DeMets DL (1996) Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group N Engl J Med. 1996; 335: 1107-14 Parker JD, Thiessen JJ (2004) Increased endothelin-1 production in patients with chronic heart failure Am J Physiol Heart Circ Physiol. 2004, 286 :H1141-H1145 Pedersen HD (1999) Echocardiographic mitral valve prolapse in cavalier King Charles spaniels: epidemiology and prognostic significance for regurgitation Vet Rec. 1999; 144: 315 PEDERSEN HD, HGGSTRM J, FALK T, MOW T, OLSEN LH, IVERSEN L ET AL (1999) Auscultation in mild mitral regurgitation in dogs: observer variation, effects of physical maneuvers, and agreement with color doppler echocardiography and phonography J Vet Intern Med., 1999; 13: 56-64 PEDERSEN HD (2000) Mitral valve prolapse in the dog: pathogenesis, pathophysiology, diagnosis and comparative aspects of early myxomatous mitral valve disease Thse Med Vet., Copenhague, 2000; 100p Peery GJ, Wei CC, Hankes GH, Dillon SR, Ryndres P, Mukherjee R, et al (2002) Angiotensin II receptor blockade does not improve left ventricular function and remodelling in subacute mitral regurgitation in the dog J Am Coll Cardiol. 2002; 39: 1374-9 PLUMB DC (2005) Veterinary drug handbook (fifth edition) Stockholm: PharmaVet, Inc; 2005 Pouchelon JL, Jamet N, Gouni V, Tissier R, Serres F, Carlos Sampedrano C, Castaignet M, Lefebvre HP, Chetboul V (2008) Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: a restrospective study of 141 cases J Vet Intern Med. 2008; 22: 905-14 Ponikowski P, Chua TP, Piepoli M, Ondusova D, Webb-Peploe K, Harrington D, Anker SD, Volterrani M, Colombo R, Mazzuero G, Giordano A, Coats AJ (1997) Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure Circulation. 1997; 96:2586-94 Reynolds C, Oyama M (2008) Intrt des biomarqueurs en cardiologie Veterinary Focus. 2008; 18: 2-6 Riegger AJ (1990) Interaction between atrial natriuretic peptide, renin system and vasopressin in heart failure Eur Heart J. 1990; 11: S79-83 Roche BM, Schwartz D, Lehnhard RA, McKeever KH, Nakayama T, Kirby TE, Robitaille PM, Hamlin RL (2002) Changes in concentrations of neuroendocrine hormones and catecholamines in dogs with myocardial failure induced by rapid ventricular pacing. Am J Vet Res. 2002; 63: 1413-17 Rosenthal SL, Ferguson MJ, Lefbom MK, Tyrrel WD (2006) Association of pimobendan with ventricular arrhythmias in dogs with congestive heart failure J Vet Intern Med. 2006; 20: 731 Rousselot JF (2000) Effet dun IECA sur la pression artrielle chez le chien insuffisant cardiaque Prat Med Chir Anim Cie. 2000; 35: 29-34 Rush JE, Freeman LM, Brown DJ, Brewer BP, Ross JN, Markwell PJ (2000) Clinical, Echocardiographic, and Neurohormonal Effects of a Sodium-Restricted Diet in Dogs with Heart Failure J Vet Intern Med. 2000; 14: 51320 Rush JE, Lee ND, Freeman LM, Brewer B (2006) C-reactive protein concentration in dogs with chronic valvular disease J Vet Intern Med. 2006; 20: 635-9 Serfass P, Chetboul V, Sampedrano CC, Nicolle A, Benalloul T, Laforge H, Gau C, Hbert C, Pouchelon JL, Tissier R (2006) Retrospective study of 942 small-sized dogs: Prevalence of left apical systolic heart murmur and left-sided heart failure, critical effects of breed and sex J Vet Cardiol. 2006; 8: 11-8 Serres FJ, Chetboul v, Tissier R, Sampedrano CC, Gouni V, Nicolle AP, Pouchelon JL (2006) Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001-2005) J Am Vet Med Assoc. 2006; 229: 1772-8 Serres F, Chetboul V, Tissier R, Sampedrano CC, Gouni V, Nicolle AP, Pouchelon JL (2007) Chordae tendineae rupture in dogs with degenerative mitral valve disease: prevalence, survival, and prognostic factors (114 cases, 2001-2006) J Vet Intern Med. 2007; 21: 258-64 Serres S, Chetboul V, Tissier R, Poujol L, Gouni V, Carlos Sampedrano C, Pouchelon JL (2008) Comparison of 3 ultrasound methods for quantifying left ventricular systolic function: correlation with disease severity and pronostic value in dogs with mitral valve disease, J Vet Interne Med. 2008; 22: 566-77 SISSON D, KITTLESON MD (1999) Management of heart failure: principles of treatment, therapeutic strategies, and pharmacology In: Fox PR, Sisson D, Mose NS, editors, 2nd ed. Philadelphia WB Saunders, Textbook of canine and feline cardiology: principles and clinical practice, 1999; 216-250 SISSON D, KVART C, DARKE PGG (1999) Acquired valvular heart disease in dogs and cats In: Fox PR, Sisson D, Mose NS, editors, 2nd ed. Philadelphia: WB Saunders, Textbook of canine and feline cardiology: principles and clinical practice ; 536-565 Slupe JL, LM Freeman, JE Rush (2008) Association of body weight and body condition with survival in dogs with heart failure J Vet Intern Med. 2008; 22: 561-5 Smith P (2006) Management of chronic degenerative mitral valve disease in dogs In Practice. 2006; 28: 376-383 Smith PJ, French AT, Van Isral N, Smith SGW, Swift ST, Lee AJ, Corcoran BM, Dukes-McEwan J (2005) Efficacy and safety of pimobendane in canine heart failure caused by myxomatous mitral valve disease J of Small Anim Pract. 2005; 46: 121-130 Souilem W, Barhoumi K (2005) Principe actif le furosmide Nouv Prat Vt canine fline. 2005; 22: 67-68 SOUILEM W, GOGNY M (2002) Principe actif la digoxine Nouv Prat Vt canine fline. 2002; 8: 55-56 Stepien RL (2009) Pulmonary arterial hypertension secondary to chronic left-sided cardiac dysfunction in dogs J of Small Anim Pract. 2009; 50: S34-43 Stewart JA Jr, Wei CC, Brower GL, Rynders PE, Hankes GH, Dillon AR, Lucchesi PA, Janicki JS, Dell'Italia LJ (2003) Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog J Mol Cell Cardiol. 2003; 35: 311-9 Swenson L, Hggstrm J, Kvart C, Juneja RK (1996) Relationship between parental cardiac status in Cavalier King Charles Spaniels and prevalence and severity of chronic valvular disease in offspring J Am Vet Med Assoc. 1996; 208: 2009-12 Teerlink JR (1996) Neurohumoral mechanisms in heart failure: a central role for the renin-angiotensin system J Cardiovasc Pharmacol. 1996; 27: S1-S8 Tessier-Vetzel D (2002) Endothlines et peptides natriurtiques, une prise en charge de linsuffisance cardiaque Action Vt. Edition spciale: cardiologie. 2002; 20-23 TESSIER-VETZEL D (2004) Insuffisance cardiaque congestive: dme pulmonaire et panchements In: Chetboul V, Lefebvre HP, Tessier-Vetzel D, Pouchelon JL, editors, Thrapeutique cardiovasculaire du chien et du chat. Paris: Masson-AFVAC; 2004, 141-53 Thomason JD, Rockwell JE, Fallaw TK, Calvert CA (2007) Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease J Vet Cardiol. 2007; 9: 103-8 Tilley LP, Smith FWK, Oyama MA, Sleeper MM (date?) Acquired valvular heart disease in dogs and cats In: Manual of canine and feline cardiology 4th edition (page?) Uechi M, Iasayama N, Mizuno T, Ebisawa T, Yamano S, Mizuno M, Mizukoshi T (2008) Hemodynamic effects of the combination of carvedilol and pimobendan in dogs Je narrive plus remettre la main sur la reference Vandaele E (2001) Traitement de linsuffisance cardiaque congestive. Le pimobendane, un vasodilatateur inotrope Point Vt. 2001; Hors srie n1106 Vandale E (2004) Traitement des endocardioses chez le chien. Le pimobendane se rvle au moins aussi efficace que les IECA Point Vt. 2004; 265: 6139-45 Ware WA Lund DD, Subieta AR, Schmid PG (1990) Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy J Am Vet Med Assoc. 1990; 197: 1475-1481 WHITNEY JC (1974) Observations of the effect of age on the severity of heart valve lesions in the dog J Small Anim Pract. 1974; 15: 511-522 YANG SS, HAN W, ZHOU HY, Dong G, Wang BC, Huo H, Wei N, Cao Y, Zhou G, Xiu CH, Li WM (2008) Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure Chin Med J. (Engl) 2008; 121: 38-42 The IMPROVE Study Group (1995) Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study J Vet Intern Med. 1995; 9: 234-42 The COVE Study Group (1995) Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group J Vet Intern Med. 1995; 9: 243-52 The BENCH Study Group (1999) The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: result of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trail: results of the BENazepril in Canine Heart Disease Journal of Veterinary Cardiology. 1999; 1: 7-18 The BENCH Study Group (2004) Long-term tolerability of benazepril in dogs with congestive heart failure Journal of veterinary Cardiology. 2004; 6: 7-13 >Rbc [   w  7 p q V W i z {  ? :;DŽ謝thŽ`h)yLhCm~;h~hCm~;mH sH h{hCm~6B*ph h{hCm~6B*mH phsH h{hCm~B*phh{hCm~B*mH phsH  h{hCm~;B*mH phsH h~hCm~6 h~hCm~h~hCm~;h)yLhCm~6h)yLhCm~6mH sH h)yLhCm~mH sH h)yLhCm~;mH sH %>bc  [   x  7 p q W z {  > ^gdCm~ & FgdCm~p> ? :;Lj>?^3p & FgdCm~^gdCm~DKLj>?]+p34D  ;Z(h~w hvhCm~hvhCm~;hzchCm~6 hv hCm~h)yLhCm~6mH sH  h{hCm~6B*mH phsH h{hCm~B*mH phsH  h{hCm~;B*mH phsH h)yLhCm~;mH sH h)yLhCm~;h)yLhCm~6h)yLhCm~mH sH  h)yLhCm~.34E ;YZv'(i&LM & FgdCm~^gdCm~hi&M()BCDy/0  Nf<\]üҨ堔Ҩwh)yLhCm~6H*mH sH hv$hCm~6 hv$hCm~hv$hCm~;mH sH hv$hCm~;h)yLhCm~;mH sH hzchCm~6 hzchCm~h)yLhCm~6 h)yLhCm~h)yLhCm~mH sH h)yLhCm~;h)yLhCm~6mH sH hvhCm~6 hhCm~.)CDy/0  OefgdCm~ & FgdCm~^gdCm~f<\](MN_  6 s !!!3"T"^gdCm~ & FgdCm~(N  6 q !!!3"T"U"o"p""""<##$$$$V${$|$$$;%`%% &b&c&~&&&&&ҿҸ~rh~hCm~6mH sH h~hCm~6 h~hCm~h)yLhCm~6 h)yLhCm~h)yLhCm~;h)yLhCm~;mH sH hzchCm~6 hzchCm~hzchCm~;hvhCm~mH sH hhCm~6mH sH hhCm~mH sH h)yLhCm~6mH sH h)yLhCm~mH sH ,T"U"p""""=##$$$V${$|$$;%_%`%% &b&c&&&&&('^gdCm~ & FgdCm~^gdCm~&'''''0(1((().)/)W))))0*M*~*** +M+S+ ,),*,+,w, ->-?-H-g------ ....ž舀yrjhvhCm~6 hvhCm~ hhCm~hvhCm~;hzchCm~6mH sH hzchCm~mH sH hhCm~6mH sH hhCm~mH sH h{hCm~6 h{hCm~h)yLhCm~6 h)yLhCm~h)yLhCm~;h)yLhCm~6mH sH h)yLhCm~mH sH h)yLhCm~;mH sH )(''''1((((().)/)X)))))0*L*M*** + +T+ ,*,+, & FgdCm~^gdCm~+,x, ->-?-p----......////0000,1T1U1r112gdCm~^gdCm~ & FgdCm~../////00000,1U1r111222E2F2233/30333333"4?4@4v444455@5_5Ž|k h{hCm~6B*mH phsH h{hCm~B*mH phsH h{hCm~B*ph h{hCm~;B*mH phsH hhCm~6 hhCm~ hhCm~hhCm~;h)yLhCm~6mH sH h)yLhCm~mH sH h)yLhCm~;mH sH h)yLhCm~6 h)yLhCm~h)yLhCm~;*22F2233033333"4?4@4w44445@5_5`5}55)6*6R6 & FgdCm~^gdCm~_5`5|5}55)6*6Q6R666666&7K77888u889:9;9N9O9x99999M:m::::;/<P<ƿƯƉwlhhCm~mH sH hhCm~6hhCm~6;hhCm~;h~hCm~6 h~hCm~hzchCm~6 hzchCm~hzchCm~;hqhCm~6 hqhCm~h)yLhCm~6h)yLhCm~;h)yLhCm~6mH sH h)yLhCm~mH sH h)yLhCm~;mH sH  h)yLhCm~'R66666&7J7K7f77888u88889:9;9O9x9999M:l:^gdCm~ & FgdCm~^gdCm~l:m:}::::;/<O<P<<=*=+=>=e=>>>>>>>????^gdCm~ & FgdCm~^gdCm~P<)=*=+=e=>>>>>>>>???????@U@f@g@@@@AALAMAB.B/BnBoBBBAC|CCCCDbDD Eƿƴⴔⴔⴔⴔ}sh~hCm~;aJhvhCm~6 hvhCm~hvhCm~;h)yLhCm~6mH sH hzchCm~6hzchCm~6mH sH h)yLhCm~mH sH  hzchCm~h)yLhCm~;mH sH h)yLhCm~;h{hCm~6 h)yLhCm~h)yLhCm~6h KhCm~6 h KhCm~-??@f@g@@@AAMAB.B/BoBBBBAC|CCCDbDDD EEEE & FgdCm~^gdCm~ E EEEEEE1FTFUFFFFFFFGGGGGH:H;HOHVHWHHHH=I>IIIIII"J_J`JoJpJJJJJJJQKyKLLL׸׸ø׸׸׸׸ø׸hvhCm~6;CJaJhvhCm~aJhvhCm~;aJh)yLhCm~6mH sH h)yLhCm~mH sH h)yLhCm~;mH sH h)yLhCm~; h)yLhCm~h)yLhCm~6h~hCm~6aJh~hCm~aJ h~hCm~4EE1FTFUFFFFFFGGGGH:H;HWHHHH>IIIII"J^gdCm~ & FgdCm~"J_J`JpJJJJJQKxKyKLLLLL#M[M\MoMM NNXNO#O$O & FgdCm~^gdCm~^gdCm~LLLL#M[M\MnMMN#O$OOOO1P8P9PPPP Q@QAQQQARdReRRSS˻ڻ˛ph\Q˻h)yLhCm~mH sH h)yLhCm~;mH sH h{hCm~6 hk1\hCm~6B*mH phsH hk1\hCm~B*phhk1\hCm~B*mH phsH  hk1\hCm~;B*mH phsH hhCm~6 hhCm~h)yLhCm~6h)yLhCm~; h)yLhCm~hzchCm~6 hzchCm~hzchCm~;h)yLhCm~6mH sH hvhCm~6aJ$O7OOOO9PPPPP Q@QAQQARdReRRSSSSSTTTsTT^gdCm~ & FgdCm~SSSSTTTTsTTTTUUUUU;V[V\VoVVVV-W.WWWWWW4XWXXXmY|YYYYYzZZZZ[[[\ \\\[]Ɠh)yLhCm~aJ$mH sH h)yLhCm~;aJmH sH h{hCm~6B*phh{hCm~B*phh{hCm~;B*phh)yLhCm~6mH sH h)yLhCm~mH sH h)yLhCm~;mH sH h)yLhCm~6h)yLhCm~; h)yLhCm~4TTTUUUU;V[V\VpVVVV.WWWWW4XVXWXXmYd1$7$8$H$^gdCm~ & Fd1$7$8$H$gdCm~ & FgdCm~^gdCm~mYYYYzZZZZ[[[ \\\\[]^^%^V^^^_t___ & FgdCm~^gdCm~d1$7$8$H$^gdCm~[]]]^V^^^^^__t______``h`i````a2a`aaaaaa1bMbYbZbӼǦtjc[th{hCm~6 h{hCm~h)yLhCm~;aJh)yLhCm~6aJmH sH h)yLhCm~aJmH sH h)yLhCm~aJh)yLhCm~;aJmH sH h)yLhCm~6aJh)yLhCm~6mH sH h)yLhCm~mH sH h)yLhCm~;mH sH  h)yLhCm~hhCm~mH sH hhCm~6H*mH sH hhCm~6mH sH #___``i````a2a_a`azaaaaa1bYbZbbZc~cccEdgdCm~^gdCm~^gdCm~ & FgdCm~ZbbbZcccccEdldmdddeeetee ffffffggggghThUhhhh(i)i:iiiii9jXjźѺѤѓ}s}hfdhCm~6aJh)yLhCm~6aJmH sH hqhCm~6 hqhCm~hzchCm~6aJh)yLhCm~;aJh)yLhCm~6mH sH h)yLhCm~mH sH h)yLhCm~;mH sH h)yLhCm~6aJh)yLhCm~aJmH sH h)yLhCm~aJh)yLhCm~;aJmH sH +Edldmdddeeeteeee ffffgggghThUhhh(i)i;i & FgdCm~^gdCm~;iiiii9jWjXjjk.k/k0kBkkkklllllmmmmon^gdCm~ & FgdCm~^gdCm~Xjjk.k0kkkkllllllmmmonnnoopQpppż؜yyyyr h)yLhCm~h)yLhCm~6mH sH h)yLhCm~mH sH h)yLhCm~6;aJh)yLhCm~;mH sH h~hCm~6aJh~hCm~;aJh~hCm~aJhhCm~6aJhhCm~aJh)yLhCm~6aJhzchCm~6aJhzchCm~aJhzchCm~;aJonnnnnooopQpppgdCm~ & FgdCm~^gdCm~ .:pCm~|. A!"#$% <@< )yLNormalCJaJmH sH tH :A@: Police par dfautVi@V Tableau Normal4 l4a 2k@2 Aucune liste<U@< )yLLien hypertexte>*B*HV@H )yLLien hypertexte suivi>*B* j  + + + + + + + + + + + + + +f+&?.4<pDALS[cjPM_ # \   >bc [x7pqWz{>?:;Lj > ? ^ 3 p   3 4 E ;YZv'(i&LM)CDy/0  Oef<\](MN_6s3TUp=V{|;_` b c  (!!!!1"""""#.#/#X#####0$L$M$$$ % %T% &*&+&x& '>'?'p''''(.(((())))****,+T+U+r++,,F,,--0-----".?.@.w..../@/_/`/}//)0*0R00000&1J1K1f11222u22223:3;3O3x3333M4l4m4}44445/6O6P667*7+7>7e788888889999?:f:g:::;;M;<.</<o<<<<A=|===>b>>> ?????1@T@U@@@@@@AAAAB:B;BWBBBB>CCCCC"D_D`DpDDDDDQExEyEFFFFF#G[G\GoGG HHXHI#I$I7IIII9JJJJJ K@KAKKALdLeLLMMMMMNNNsNNNNOOOO;P[P\PpPPPP.QQQQQ4RVRWRRmSSSSzTTTTUUU VVVV[WXX%XVXXXYtYYYYYZZiZZZZ[2[_[`[z[[[[[1\Y\Z\\Z]~]]]E^l^m^^^___t____ ````aaaabTbUbbb(c)c;ccccc9dWdXdde.e/e0eBeeeefffffggggohhhhhiiijQjjj 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0 h0h0h0h 0 h0h0h0h 0 h0h0h0h 0 h0h0h0h 0 h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0h0h0h0h 0 h0h0h0h 0!h0h0h0h 0"h0h0h0h 0#h0h0h0h 0$h0h0h0h 0%h0h0h0h 0&h0h0h0h 0'h0h0h0h 0(h0h0h0h 0)h0h0h0h 0*h0h0h0h 0+h0h0h0h 0,h0h0h0h 0-h0h0h0h 0.h0h0h0h 0/h0h0h0h 00h0h0h0h 01h0h0h0h 02h0h0h0h 03h0h0h0h 04h0h0h0h 05h0h0h0h 06h0h0h0h 07h0h0h0h 08h0h0h0h 09h0h0h0h 0:h0h0h0h 0;h0h0h0h 0<h0h0h0h 0=h0h0h0h 0>h0h0h0h 0?h0h0h0h 0@h0h0h0h 0Ah0h0h0h 0Bh0h0h0h 0Ch0h0h0h 0Dh0h0h0h 0Eh0h0h0h 0Fh0h0h0h 0Gh0h0h0h 0Hh0h0h0h 0Ih0h0h0h 0Jh0h0h0h 0Kh0h0h0h 0Lh0h0h0h 0Mh0h0h0h 0Nh0h0h0h 0Oh0h0h0h 0Ph0h0h0h 0Qh0h0h0h 0Rh0h0h0h 0Sh0h0h0h 0Th0h0h0h 0Uh0h0h0h 0Vh0h0h0h 0Wh0h0h0h 0Xh0h0h0h 0Yh0h0h0h 0Zh0h0h0h 0[h0h0h0h 0\h0h0h0h 0]h0h0h0h 0^h0h0h0h 0_h0h0h0h 0`h0h0h0h 0ah0h0h0h 0bh0h0h0h 0ch0h0h0h 0dh0h0h0h 0eh0h0h0h 0fh0h0h0h 0gh0h0h0h 0hh0h0h0h 0ih0h0h0h 0jh0h0h0h 0kh0h0h0h 0lh0h0h 0mh0h0h0h 0nh0h0h0h 0oh0h0h0h 0ph0h0h0h 0qh0h0h0h 0rh0h0h0h 0sh0i0i0i 0ti0i0i0i 0ui0i0i0i 0vi0i0i0i 0wi0i0i0i 0x000 0y0i0i0i 0zi0i0i0i 0{i0i0i0i 0|i0i0i0i 0}i0p 0p 0p ƀ 0~p ƀ0p ƀ0p ƀ0p ƀ 0p ƀ0p ƀ0p ƀ0p ƀ0p ƀ 0p ƀ0p ƀ0p ƀ0p ƀ 0p ƀ0p ƀ0p ƀ0p ƀ 0p ƀ0p ƀ0p ƀ0p ƀ 0p ƀ0p ƀ0p ƀ0p ƀ0p ƀ 0p ƀ0p ƀ0p ƀ0p ƀ 0p ƀ0p 0p 0p >bc [x7pqWz{>?:;Lj > ? ^ 3 p   3 4 E ;YZv'(i&LM)CDy/0  Oef<\](MN_6s3TUp=V{|;_` b c  (!!!!1"""""#.#/#X#####0$L$M$$$ % %T% &*&+&x& '>'?'p''''(.(((())))****,+T+U+r++,,F,,--0-----".?.@.w..../@/_/`/}//)0*0R00000&122u22223:3;3O3x3333M4l4m4}44445/6O6P667*7+7>7e788888889999?:f:g:::;;M;<.</<o<<<<A=|===>b>>> ?????1@T@U@@@@@@AAAAB:B;BWBBBB>CCCCC"D_D`DpDDDDDQExEyEFFFFF#G[G\GoGG HHXHI#I$I7IIII9JJJJJ K@KAKKALdLeLLMMMMMNNNsNNNNOOOO;P[P\PpPPPP.QQQQQ4RVRWRRmSSSSzTTTTUUU VVVV[WXX%XVXXXYtYYYYYZZiZZZZ[2[_[`[z[[[[[1\Y\Z\\Z]~]]]E^l^m^^^___t_```aaaabTbUbbb(c)c;ccccc9dWdXdde.e/e0eBeeeefffffggggohhhhhiiijQjjj 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0 ʀ0ʀ0ʀ0ʀ 0 ʀ0ʀ0ʀ0ʀ 0 ʀ0ʀ0ʀ0ʀ 0 ʀ0ʀ0ʀ0ʀ 0 ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0ʀ0ʀ0ʀ0ʀ 0 ʀ0ʀ0ʀ0ʀ 0!ʀ0ʀ0ʀ0ʀ 0"ʀ0ʀ0ʀ0ʀ 0#ʀ0ʀ0ʀ0ʀ 0$ʀ0ʀ0ʀ0ʀ 0%ʀ0ʀ0ʀ0ʀ 0&ʀ0ʀ0ʀ0ʀ 0'ʀ0ʀ0ʀ0ʀ 0(ʀ0ʀ0ʀ0ʀ 0)ʀ0ʀ0ʀ0ʀ 0*ʀ0ʀ0ʀ0ʀ 0+ʀ0ʀ0ʀ0ʀ 0,ʀ0ʀ0ʀ0ʀ 0-ʀ0ʀ0ʀ0ʀ 0.ʀ0ʀ0ʀ0ʀ 0/ʀ0ʀ0ʀ0ʀ 00ʀ0ʀ0ʀ0ʀ 01ʀ0ʀ0ʀ0ʀ 02ʀ0ʀ0ʀ0ʀ 03ʀ0ʀ0ʀ0ʀ 04ʀ0ʀ0ʀ0ʀ 05ʀ0ʀ0ʀ0ʀ 06ʀ0ʀ0ʀ0ʀ 07ʀ0ʀ0ʀ0ʀ 08ʀ0ʀ0ʀ0ʀ 09ʀ0ʀ0ʀ0ʀ 0:ʀ0ʀ0ʀ0ʀ 0;ʀ0ʀ0ʀ0ʀ 0<ʀ0ʀ0ʀ0ʀ 0=ʀ0ʀ0ʀ 0>ʀ0ʀ0ʀ0ʀ 0?ʀ0ʀ0ʀ0ʀ 0@ʀ0ʀ0ʀ0ʀ 0Aʀ0ʀ0ʀ0ʀ 0Bʀ0ʀ0ʀ0ʀ 0Cʀ0ʀ0ʀ0ʀ0j#50ʀ0ʀ0ʀ 0Cʀ0ʀ0ʀ0ʀ 0Dʀ0ʀ0ʀ0ʀ 0Eʀ0ʀ0ʀ0ʀ 0Fʀ0ʀ0ʀ0ʀ 0Gʀ0ʀ0ʀ0ʀ 0Hʀ0ʀ0ʀ0ʀ 0Iʀ0ʀ0j#.:0j#.:@0@00ʀ0ʀ 0Jʀ0ʀ0ʀ0ʀ 0Kʀ0ʀ0ʀ0ʀ 0Lʀ0ʀ0ʀ0ʀ 0Mʀ0ʀ0ʀ0ʀ 0Nʀ0ʀ0ʀ0ʀ 0Oʀ0ʀ0ʀ0ʀ 0Qʀ0ʀ0ʀ0ʀ 0Rʀ0ʀ0ʀ0ʀ 0Sʀ0ʀ0ʀ0ʀ 0Tʀ0ʀ0ʀ0ʀ 0Uʀ0ʀ0ʀ00ʀ0ʀ0ʀ0ʀ 0Vʀ0ʀ0ʀ0ʀ 0Wʀ0ʀ0ʀ0ʀ 0Xʀ0ʀ0ʀ0ʀ 0Yʀ0ʀ0ʀ0ʀ 0Zʀ0ʀ0ʀ0ʀ 0[ʀ0ʀ0ʀ0ʀ 0\ʀ0ʀ0ʀ0ʀ 0]ʀ0ʀ0ʀ0ʀ 0Yʀ0ʀ0ʀ0ʀ 0Zʀ0ʀ0ʀ0ʀ 0[ʀ0ʀ0ʀ0ʀ 0\ʀ0ʀ0ʀ0ʀ 0]ʀ0ʀ0ʀ0ʀ 0^ʀ0ʀ0ʀ0ʀ 0_ʀ0ʀ0ʀ0ʀ 0`ʀ0ʀ0ʀ0ʀ 0aʀ0ʀ0ʀ0ʀ 0bʀ0ʀ0ʀ0ʀ 0cʀ0ʀ0ʀ 0dʀ0ʀ0ʀ0ʀ 0eʀ0ʀ0ʀ0ʀ 0fʀ0ʀ0ʀ0ʀ 0gʀ0ʀ0ʀ0ʀ 0hʀ0ʀ0ʀ0ʀ 0iʀ0ʀ0ʀ0ʀ 0jʀ0ʀ0ʀ0ʀ 0kʀ0ʀ0ʀ0ʀ 0lʀ0ʀ0ʀ0ʀ 0mʀ0ʀ0ʀ0ʀ 0nʀ0ʀ0ʀ0ʀ 0oʀ0ʀ0ʀ0ʀ 0pʀ0ʀ0ʀ0ʀ 0qʀ0ʀ0ʀ0ʀ 0rʀ0ʀ0ʀ0ʀ 0sʀ0ʀ0ʀ0ʀ 0tʀ0ʀ0ʀ0ʀ 0uʀ0ʀ0ʀ0ʀ0ʀ 0vʀ0ʀ0ʀ0ʀ 0wʀ0ʀ0ʀ0ʀ 0xʀ0ʀ0ʀ0ʀ 0yʀ0ʀ0ʀ0ʀ0ʀ 0zʀ0ʀ0ʀ0ʀ 0lʀ 0a 0p 0ppDh&._5P< ELS[]ZbXjp:>@CEHJMORTWY\> fT"('+,2R6l:?E"J$OTmY_Ed;ionp;=?ABDFGIKLNPQSUVXZ[]p<j _Hlt138955223 _Hlt112747060eLaj@@qLaj,78:Yaekot~   9B ",.0;@EFHJP[^_eistwx{|"7@gn!'NR]d  )-9GNRVINOQS\`f}#$';B^ijnptvy   " ? G H J L S T V      ! A K S p |         ) 3 6 7 < = B C G H L M T b o r u v | }    $ % 4 5 8 9 C Q U V Z b o p |    ! 4 ; d g  "$16:;?@CDGZ`acekv}(15<@GKOS[_gkrv{  +8:>FNPST_`hiklq$,018MUYbcegu$')-DLdnrw{ *0+.049CGRdijlnuy~9Afnoq  #$./;<>ADEH]dhrNSTW_g"&,DOPX\cdijqu&'/08:BFINQRUW_jrU\`f~ (HQRY %&+,37:CI^bch %3:;EFLhoy{     & , - 2 3 ; G N c j o t !!!!!!!!!!""1">"C"T"["c"d"s"t"~""""""""""""""""""""### ##6#8#X#b###########M$V$a$c$e$l$p$u$ %%%!%%%-%2%7%;%@%D%J%T%[%_%h%i%r%s%w%x%%%%%%%%%%%%%%%%%%%%% & & &&&&&+&4&&&&&&'?'H'L'S'T'\'`'e'}'''''''''''''''''((((((( (%(&(-(3(;(@(G(H(J(U(](a(k(l(t(u(}(((((((((((((((((((((((()))))))()0)4)>)?)G)H)P)R)Z)^)a)f)i)j)m)o)w)))))))))))G*O*P*Z*[*a********* ++++7+;+<+A+U+[+\+^+`+h+r+|+++++++++++++++++,,,,,,/,1,V,d,,,,,,,-----.. . ....".$.%.*.@.I.M.S.W.].^.`.b.m.........///#/J/M/j/r/s/u///////40=0A0H000000000000000001 1 1111(1+1,1213161K1R1V1\111222 222 2#2-272;2F2G2R2S2a2b2e2f2k2l2t2u2~222222222222222223333333 3!3&3;3D3E3G3O3Y3Z3j3k3w3|33333333333333333 4&4/4M4Q4R4Y4m4s44444444444444555555%5)5/535:5>5C5G5L5X5_5c5j5v5~55555555555555555555566 6 6 66!6.6164656;6<6?6P6X6\6j6~6666666666666666666666666677 7777774767i7q777777777 88:8F888888899999999:%:&:.:D:H:g:n:o:q:::::::C<N<R<X<z<<<<<<<<=== = ====#=%=7=9=H=U=Z=b=c=m=n=s=t={=~====================>>> >!>+>?>C>D>H>I>P>Q>Y>Z>a>d>g>h>n>o>r>>>>>>>>>>>>>>>>> ????+?0?1?6?@?D?E?M?N?S?T?[?_?b?c?i?}????????????????? @@"@&@0@3@6@7@=@>@A@U@Y@Z@\@^@h@m@r@s@u@w@~@@@@@@@@@AAlAvAzAAAAAAAAAA6B9B;B@BCC CCDDyEEEEEEEEEEEEEEEEEEEEF FFFF'F(F+F,F5F9F?F@FGFHFMFNFUFcFmFnFxFyFFFFFFFFFFFFFFFFG G GGGGG!G#G%G(G/G0G5G6G:G;GBG\GdGeGgGoGGGGGGGGGGGGGGGGGGGGHHHHH$H0H3H=H?HAHHHhHlHtHHHHHHHHHHHHHHHHHHHHHHIII I II$I,I-I/IDILIPISIYIeIgIvIxIIIIIIIIIIIIIIIIJJJ(J9JDJJJJJJJJKKKKKKKKK+K4K6K9KAKJKOKTKKKKKL-LeLoLsLwL|LLLLLLLLLLLLLLLLLLLMMMM M&M/M9MCMDMNMOMRMSM\M]MfMjMqMrMwMxMMMMMMMMMMN N N N)N/N0N;NENJNsNvNNNNNNNNNNNNNNNNNNN-O0O1O?OCOGOHOLOMOWOXO_O`OgOkOpOqO|O}OOOOOOOOOOOOOOOO{PPPPPPPPPPQQQ#Q$Q&Q8QIQOQ\QQQQQ#R+RWR^RbRjRnRxR}RRRRRRRRRRRRRRRRsSzSSSSSSSSSSSSSSSSTTTTTT&T7T;TbCbJbUbZb^bfbtb{bbbbbbbbbbbbbbbccc ccc)c1cqc|cccccccccc d4d8d?dBdXd\d]d_didpdud{d|d~ddddddddddddddddddddddee e e eeeeeReUeVe\egejekesewe|eeeeeeeeeeeeeeeeeeffffff f$f2f6f@fAfDfPfZfsfxfyffffffffffffggg#gkgvgwgggg hhYhbhhh"i-iii j*jj`e4[".RY'AV~Z~Z~~~~99Z~~~9Z~~9~~~~~~~Z~99~~s~~~~9~~Z9~~~ZE{>~~Z~~s~~~Z~1{~~~~~~~1~~~~{~{~~s~{~~{~~~s{~{~~~~~~s~{~Z~~{~~~R~~Z ?;~Z~~~R{~~~~~R~~{~~9~~9~~~~{~~~~~~{~s~~~{Z{~s~~~~s9~~9~~~~93A9~~~~~~~~~~~99ZZ~~~  so{wo{swo{so{o{wwkZswo{wwo{o{so{swo{o{kZso{kZwo{sw swkZswo{wso{o{ww2kZVZ^Vg9g9wZcVZVV^kZ^ZVg9Z^ZR^ZZRg9wV^kZ^cRkZV^kZg9Zg9Vg9^kZg9VkZ?swswwswwsww=Z^kZRg9^^c^NsNsVkZ^NsRZZkZRV^ZVkZNs^o{F1Vg9VNs^o{VNsRo{^^JRo{ZZVZVc^^o{RZ^ZZwo{ZVZcg93wwwswsswswAg9c^Z^Rc^VRVcVVZg9VwkZkZg9^g9  o{o{o{sw skZo{wwwkZwsso{kZskZwwwo{wo{wkZwwo{o{wwo{ o{wo{so{o{w>ZV^ZZZwg9g9wVcZwZco{g9ZcVZwZRNskZZcRg9g9RZ^Ns^ccwccRg9V^VVwccZ^^Zw1swwkZo{wkZo{o{wwso{wo{w1^Z^kZVZwkZcNsckZg9VkZVkZ=o{ssswwwwww8^kZkZZVccZkZg9Vo{ZZkZVF1ZJRZg9^Zo{cNso{ZVZcg9^kZNsZNs^o{BNsc^o{o{ZcRo{^VkZwwwwc*o{^c^o{ZNs^ZZcV^g9^VcRZkZZRNsR^g9Ro{kZo{NscVV^Vo{g9^Vg9^ 0wwwsswsswwAg9c^Z^Rc^VRVcVkZVg9^wg9g9kZVkZ  1o{o{o{wwwo{o{wo{wso{o{sw1^VcRg9ZRVkZ^kZg9VVkZkZ#sswww9co{o{Nso{^^VV^kZ^^Nso{ZV^ZVF1^?wwwwswwso{wwwswwORVcg9^cZR^g9w^Z^V^kZ^ wg9VVo{g9kZVVsZg9              ՜.+,0 hp  'ENVL*e 1 Titre  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F771Table_*WordDocument0SummaryInformation( DocumentSummaryInformation8CompObjX FDocument Microsoft WordNB6WWord.Document.8